References
- H. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal and F. Bray, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin. 71(3) (2021) 209–249; https://doi.org/10.3322/caac.21660
- W. D. Travis, E. Brambilla and G. J. Riely, New pathologic classification of lung cancer: relevance for clinical practice and clinical trials, J. Clin. Oncol. 31(8) (2013) 992–1001; https://doi.org/10.1200/jco.2012.46.9270
- A. T. Fathi and J. R. Brahmer, Chemotherapy for advanced stage non-small cell lung cancer, Semin. Thorac. Cardiovasc. Surg. 20(3) (2008) 210–216; https://doi.org/10.1053/j.semtcvs.2008.09.002
- A. Díaz-Serrano, P. Gella, E. Jiménez, J. Zugazagoitia and L. Paz-Ares Rodríguez, Targeting EGFR in lung cancer: Current standards and developments, Drugs 78(9) (2018) 893–911; https://doi.org/10.1007/s40265-018-0916-4
- M. Maemondo, A. Inoue, K. Kobayashi, S. Sugawara, S. Oizumi, H. Isobe, A. Gemma, M. Harada, H. Yoshizawa, I. Kinoshita, Y. Fujita, S. Okinaga, H. Hirano, K. Yoshimori, T. Harada, T. Ogura, M. Ando, H. Miyazawa, T. Tanaka, Y. Saijo, K. Hagiwara, S. Morita and T. Nukiwa, Gefitinib or chemo-therapy for non-small-cell lung cancer with mutated EGFR, N. Engl. J. Med. 362(25) (2010) 2380–2388; https://doi.org/10.1056/NEJMoa0909530
- M. Reck, D. Rodríguez-Abreu, A. G. Robinson, R. Hui, T. Csőszi, A. Fülöp, M. Gottfried, N. Peled, A. Tafreshi, S. Cuffe, M. O’Brien, S. Rao, K. Hotta, M. A. Leiby, G. M. Lubiniecki, Y. Shentu, R. Rang-wala and J. R. Brahmer, Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer, N. Engl. J. Med. 375(19) (2016) 1823–1833; https://doi.org/10.1056/NEJMoa1606774
- J. Xie, J. Liu, H. Liu, S. Liang, M. Lin, Y. Gu, T. Liu, D. Wang, H. Ge and S. L. Mo, The antitumor effect of tanshinone IIA on anti-proliferation and decreasing VEGF/VEGFR2 expression on the human non-small cell lung cancer A549 cell line, Acta Pharm. Sin. B. 5(6) (2015) 554–563; https://doi.org/10.1016/j.apsb.2015.07.008
- H. Luo, C. T. Vong, H. Chen, Y. Gao, P. Lyu, L. Qiu, M. Zhao, Q. Liu, Z. Cheng, J. Zou, P. Yao, C. Gao, J. Wei, C. O. L. Ung, S. Wang, Z. Zhong and Y. Wang, Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine, Chin. Med. 14 (2019) Article ID 48 (58 pages); https://doi.org/10.1186/s13020-019-0270-9
- M. Kluska and K. Woźniak, Natural polyphenols as modulators of etoposide anti-cancer activity, Int. J. Mol. Sci. 22(12) (2021) Article ID 6602 (16 pages); https://doi.org/10.3390/ijms22126602
- J. Liang, N. Bi, S. Wu, M. Chen, C. Lv, L. Zhao, A. Shi, W. Jiang, Y. Xu, Z. Zhou, W. Wang, D. Chen, Z. Hui, J. Lv, H. Zhang, Q. Feng, Z. Xiao, X. Wang, L. Liu, T. Zhang, L. Du, W. Chen, Y. Shyr, W. Yin, J. Li, J. He and L. Wang, Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial, Ann. Oncol. 28(4) (2017) 777–783; https://doi.org/10.1093/annonc/mdx009
- Y. Yoneshima, S. Morita, M. Ando, A. Nakamura, S. Iwasawa, H. Yoshioka, Y. Goto, M. Takeshita, T. Harada, K. Hirano, T. Oguri, M. Kondo, S. Miura, Y. Hosomi, T. Kato, T. Kubo, J. Kishimoto, N. Yamamoto, Y. Nakanishi and I. Okamoto, Phase 3 trial comparing nanoparticle albumin-bound paclitaxel with docetaxel for previously treated advanced NSCLC, J. Thorac. Oncol. 16(9) (2021) 1523–1532; https://doi.org/10.1016/j.jtho.2021.03.027
- X. Jiang, W. Zhao, F. Zhu, H. Wu, X. Ding, J. Bai, X. Zhang and M. Qian, Ligustilide inhibits the proliferation of non-small cell lung cancer via glycolytic metabolism, Toxicol. Appl. Pharmacol. 410 (2021) Article ID 115336 (25 pages); https://doi.org/10.1016/j.taap.2020.115336
- J. Zou, Y. Yang, Y. Yang and X. Liu, Polydatin suppresses proliferation and metastasis of non-small cell lung cancer cells by inhibiting NLRP3 inflammasome activation via NF-κB pathway, Biomed. Pharmacother. 108 (2018) 130–136; https://doi.org/10.1016/j.biopha.2018.09.051
- A. Ashaq, M. F. Maqbool, A. Maryam, M. Khan, H. A. Shakir, M. Irfan, J. I. Qazi, Y. Li and T. Ma, Hispidulin: A novel natural compound with therapeutic potential against human cancers, Phytother. Res. 35(2) (2021) 771–789; https://doi.org/10.1002/ptr.6862
- K. S. Prabhu, A. A. Bhat, K. S. Siveen, S. Kuttikrishnan, S. S. Raza, T. Raheed, A. Jochebeth, A. Q. Khan, M. Z. Chawdhery, M. Haris, M. Kulinski, S. Dermime, M. Steinhoff and S. Uddin, Sanguinarine mediated apoptosis in non-small cell lung cancer via generation of reactive oxygen species and suppression of JAK/STAT pathway, Biomed. Pharmacother. 144 (2021) Article ID 112358 (11 pages); https://doi.org/10.1016/j.biopha.2021.112358
- Y. Chen, L. Yin, M. Hao, W. Xu, J. Gao, Y. Sun, Q. Wang, S. Chen, Y. Liang, R. Guo, J. Zhang, J. Li, Q. Zhai, R. Cheng, J. Wang, H. Wang and Z. Yang, Medicarpin induces G1 arrest and mitochondria-mediated intrinsic apoptotic pathway in bladder cancer cells, Acta Pharm. 73(2) (2023) 211–225; https://doi.org/10.2478/acph-2023-0016
- J. H. Kim, D. M. Kang, Y. J. Cho, J. W. Hyun and M. J. Ahn, Medicarpin increases antioxidant genes by inducing NRF2 transcriptional level in HeLa cells, Antioxidants (Basel) 11(2) (2022) Article ID 421 (10 pages); https://doi.org/10.3390/antiox11020421
- B. Bhargavan, D. Singh, A. K. Gautam, J. S. Mishra, A. Kumar, A. Goel, M. Dixit, R. Pandey, L. Manic-kavasagam, S. D. Dwivedi, B. Chakravarti, G. K. Jain, R. Ramachandran, R. Maurya, A. Trivedi, N. Chattopadhyay and S. Sanyal, Medicarpin, a legume phytoalexin, stimulates osteoblast differentiation and promotes peak bone mass achievement in rats: evidence for estrogen receptor β-mediated osteogenic action of medicarpin, J. Nutr. Biochem. 23(1) (2012) 27–38; https://doi.org/10.1016/j.jnutbio.2010.11.002
- A. M. Tyagi, A. K. Gautam, A. Kumar, K. Srivastava, B. Bhargavan, R. Trivedi, S. Saravanan, D. K. Yadav, N. Singh, C. Pollet, M. Brazier, R. Mentaverri, R. Maurya, N. Chattopadhyay, A. Goel and D. Singh, Medicarpin inhibits osteoclastogenesis and has nonestrogenic bone conserving effect in ovariectomized mice, Mol. Cell. Endocrinol. 325(1–2) (2010) 101–109; https://doi.org/10.1016/j.mce.2010.05.016
- G. Gatouillat, A. A. Magid, E. Bertin, H. El btaouri, H. Morjani, C. Lavaud and C. Madoulet, Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells, Phytomedicine 22(13) (2015) 1186–1194; https://doi.org/10.1016/j.phymed.2015.09.005
- R. Trivedi, R. Maurya and D. P. Mishra, Medicarpin, a legume phytoalexin sensitizes myeloid leukemia cells to TRAIL-induced apoptosis through the induction of DR5 and activation of the ROSJNK-CHOP pathway, Cell Death Dis. 5(10) (2014) e1465; https://doi.org/10.1038/cddis.2014.429
- A. K. Yiğin, H. Donmez, M. Hitit, S. Seven, N. Eser, E. Kurar and M. Seven, The effect of medicarpin on PTEN/AKT signal pathway in head and neck squamous cell carcinoma, J. Cancer Res. Ther. 18(1) (2022) 180–184; https://doi.org/10.4103/jcrt.jcrt_641_21
- A. Mohr, L. Deedigan, S. Jencz, Y. Mehrabadi, L. Houlden, S. M. Albarenque and R. M. Zwacka, Caspase-10: a molecular switch from cell-autonomous apoptosis to communal cell death in response to chemotherapeutic drug treatment, Cell Death Differ. 25(2) (2018) 340–352; https://doi.org/10.1038/cdd.2017.164
- H. S. Chin, M. X. Li, I. K. L. Tan, R. L. Ninnis, B. Reljic, K. Scicluna, L. F. Dagley, J. J. Sandow, G. L. Kelly, A. L. Samson, S. Chappaz, S. L. Khaw, C. Chang, A. Morokoff, K. Brinkmann, A. Webb, C. Hockings, C. M. Hall, A. J. Kueh, M. T. Ryan, R. M. Kluck, P. Bouillet, M. J. Herold, D. H. D. Gray, D. C. S. Huang, M. F. van Delft and G. Dewson, VDAC2 enables BAX to mediate apoptosis and limit tumor development, Nat. Commun. 9(1) (2018) Article ID 4976 (13 pages); https://doi.org/10.1038/s41467-018-07309-4
- H. Xian and Y. C. Liou, Loss of MIEF1/MiD51 confers susceptibility to BAX-mediated cell death and PINK1-PRKN-dependent mitophagy, Autophagy 15(12) (2019) 2107–2125; https://doi.org/10.1080/15548627.2019.1596494
- L. Bai, H. M. Ni, X. Chen, D. DiFrancesca and X. M. Yin, Deletion of Bid impedes cell proliferation and hepatic carcinogenesis, Am. J. Pathol. 166(5) (2005) 1523–1532; https://doi.org/10.1016/s0002-9440(10)62368-1
- A. Wree, C. D. Johnson, J. Font-Burgada, A. Eguchi, D. Povero, M. Karin and A. E. Feldstein, Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation, Cell Death Differ. 22(12) (2015) 1985–1994; https://doi.org/10.1038/cdd.2015.46
- M. J. Morgan and Z. G. Liu, Crosstalk of reactive oxygen species and NF-κB signaling, Cell Res. 21(1) (2011) 103–115; https://doi.org/10.1038/cr.2010.178
- C. Yu, S. Yan, B. Khambu, X. Chen, Z. Dong, J. Luo, G. K. Michalopoulos, S. Wu and X. M. Yin, Gene expression analysis indicates divergent mechanisms in DEN-induced carcinogenesis in wild type and Bid-deficient livers, PLoS One 11(5) (2016) e0155211; https://doi.org/10.1371/journal.pone.0155211
- S. H. Moon, C. H. Huang, S. L. Houlihan, K. Regunath, W. A. Freed-Pastor, J. P. t. Morris, D. F. Tschaharganeh, E. R. Kastenhuber, A. M. Barsotti, R. Culp-Hill, W. Xue, Y. J. Ho, T. Baslan, X. Li, A. Mayle, E. de Stanchina, L. Zender, D. R. Tong, A. D’Alessandro, S. W. Lowe and C. Prives, p53 represses the mevalonate pathway to mediate tumor suppression, Cell 176(3) (2019) 564–580; https://doi.org/10.1016/j.cell.2018.11.011
- D. Reddy, R. Kumavath, P. Ghosh and D. Barh, Lanatoside C induces G2/M cell cycle arrest and suppresses cancer cell growth by attenuating MAPK, Wnt, JAK-STAT, and PI3K/AKT/mTOR signaling pathways, Biomolecules 9(12) (2019) Article ID 792 (20 pages); https://doi.org/10.3390/biom9120792
- W. Hao, S. Wang and Z. Zhou, Tubeimoside-1 (TBMS1) inhibits lung cancer cell growth and induces cells apoptosis through activation of MAPK-JNK pathway, Int. J. Clin. Exp. Pathol. 8(10) (2015) 12075–12083.
- X. B. Jia, Q. Zhang, L. Xu, W. J. Yao and L. Wei, Lotus leaf flavonoids induce apoptosis of human lung cancer A549 cells through the ROS/p38 MAPK pathway, Biol. Res. 54(1) (2021) Article ID 7 (15 pages); https://doi.org/10.1186/s40659-021-00330-w
- T. Otto and P. Sicinski, Cell cycle proteins as promising targets in cancer therapy, Nat. Rev. Cancer 17(2) (2017) 93–115; https://doi.org/10.1038/nrc.2016.138
- Y. Hu, K. Yu, G. Wang, D. Zhang, C. Shi, Y. Ding, D. Hong, D. Zhang, H. He, L. Sun, J. N. Zheng, S. Sun and F. Qian, Lanatoside C inhibits cell proliferation and induces apoptosis through attenuating Wnt/β-catenin/c-Myc signaling pathway in human gastric cancer cell, Biochem. Pharmacol. 150 (2018) 280–292; https://doi.org/10.1016/j.bcp.2018.02.023
- M. Rasheduzzaman, H. Yin and S. Y. Park, Cardiac glycoside sensitized hepatocellular carcinoma cells to TRAIL via ROS generation, p38MAPK, mitochondrial transition, and autophagy mediation, Mol. Carcinog. 58(11) (2019) 2040–2051; https://doi.org/10.1002/mc.23096
- I. Durmaz, E. B. Guven, T. Ersahin, M. Ozturk, I. Calis and R. Cetin-Atalay, Liver cancer cells are sensitive to lanatoside C induced cell death independent of their PTEN status, Phytomedicine 23(1) (2016) 42–51; https://doi.org/10.1016/j.phymed.2015.11.012
- A. Rauf, T. Abu-Izneid, A. A. Khalil, M. Imran, Z. A. Shah, T. B. Emran, S. Mitra, Z. Khan, F. A. Alhu maydhi, A. S. M. Aljohani, I. Khan, M. M. Rahman, P. Jeandet and T. A. Gondal, Berberine as a potential anticancer agent: A comprehensive review, Molecules 26(23) (2021) Article ID 7368 (19 pages); https://doi.org/10.3390/molecules26237368+
- D. Bertheloot, E. Latz and B. S. Franklin, Necroptosis, pyroptosis and apoptosis: an intricate game of cell death, Cell. Mol. Immunol. 18(5) (2021) 1106–1121; https://doi.org/10.1038/s41423-020-00630-3
- D. E. Hong, J. E. Yu, J. W. Lee, D. J. Son, H. P. Lee, Y. Kim, J. Y. Chang, D. W. Lee, W. K. Lee, J. Yun, S. B. Han, B. Y. Hwang and J. T. Hong, A natural CHI3L1-targeting compound, ebractenoid f, inhibits lung cancer cell growth and migration and induces apoptosis by blocking CHI3L1/AKT signals, Molecules 28(1) (2022) Article ID 329 (16 pages); https://doi.org/10.3390/molecules28010329